HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran

Gynecologic and Obstetric Investigation

Volumn 66, Issue 1, 2008, Pages 68-72

  Esmaeili, Mohsen ^a,b   Bonyadi, Mortaza ^a,b   Dastranj, Ali ^c   Alizadeh, Masoumeh ^b   Melli, Manizheh Sayyah ^c   Shobeiri, Mehri Jafari ^c  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical cancer; Human papillomavirus; Iranian population; PCR

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IRAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS TYPING; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IRAN; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 47549109076     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134917     Document Type: Article

References (29)

1. Parkin DM, Stjernsward J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull WHO 1984;62:163-182.
2. Zur Hausen H: Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-156.
3. Zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111:581-587.
4. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004;324:17-27.
5. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
6. Burd EM: Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16:1-17.
7. Kjaer S, van den Brule AJC, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijer CJ: Type-specific persistence of high-risk human papillomavirus as indicator of high-grade cervical squamous intraepithelial lesions in young women: population-based prospective follow-up study. BMJ 2002;325:572-576.
8. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah K, Walboomers JM, Herrero R, Franceschi S, International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group: Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC Multicentric Case-Control Study. Lancet 2002;359:1085-1092.
9. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX: Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 2002;359:1093-1101.
10. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N: Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study. Cancer Causes Control 2003;14:805-814.
11. Spitzer M: Cervical screening adjuncts: recent advances. Am J Obstet Gynecol 1998;179:544-556.
12. Snijders PJ, van den Brule AJ, Meijer CJ: The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2002;201:1-6.
13. Munoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
14. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, Alihonou E, Bayo S, Mockhtar HC, Chicareon S, Daudt A, Delosrios E, Ghadirian P, Kitinya JN, Koulibaly M, Ngelangel C, Tintore LMP, Riosdalenz JL, Sarjadi A, Schneider A, Tafur L, Teyssie AR, Rolon PA, Torroella M, Tapia AV, Wabinga HR, Zatonski W, Sylla B, Vizcaino P, Magnin D, Kaldor J, Greer C, Wheeler C: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
15. Lai HG, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY: Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer 1999;84:553-557.
16. Hwang T: Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women. J Korean Med Sci 1999;14:593-599.
17. Lo KW, Cheung TH, Chung TKH, Wang VW, Poon JS, Li JCB, Lam P, Wong YF: Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers. Gynecol Obstet Invest 2001;51:202-207.
18. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein RS, Burck RD: PCR detection of human papillomavirus: comparison between MY9/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-1310.
19. Meyer T, Arndt R, Christophers E: Association of rare papillomavirus types with genital premalignant and malignant lesions. J Infect Dis 1998;178:252-255.
20. Cao W, Hashibe M, Rao JY, Morgenstern H, Zhang ZF: Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev 2003;27:397-404.
21. De Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ: The use of general primers GP5 and GP6 elongated at their 30 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062.
22. Samoylova EV, Shaikhaiev GO, Petrov SV, Kisseljova NP, Kisseljov FL: HPV infection in cervical cancer cases in Russia. Int J Cancer 1995;61:337-341.
23. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P: Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996;34:745-747.
24. Scott DA, Kraft ML, Carmi R, Ramesh A, Elbedour K, Yairi Y, Srikumari Srisailapathy CR, Rosengren SS, Markham AF, Mueller RF, Lench NJ, Van Camp G, Smith RJH, Sheffield VC: Identification of mutations in the connexin 26 gene that cause autosomal recessive non-syndromic hearing loss. Hum Mut 1998;11:387-394.
25. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121:621-632.
26. Camara GN, Cerqueira DM, Oliveira AP, Silva EO, Carvalho LG, Martins CR: Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the federal district of Brazil. Mem Inst Oswaldo Cruz 2003;98:879-883.
27. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO: In situ evidence for HPV16, 18, 33 integration in cervical squamous cell cancer in Britain and South Africa. J Clin Pathol 1991;44:406-409.
28. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W: Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517.
29. Huang LW, Chao SL, Chen PH, Chou HP: Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J Clin Virol 2004;29:271-276.